Literature DB >> 18199426

Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.

C E Adams1, J C Yonchek, L Zheng, A C Collins, K E Stevens.   

Abstract

The alpha7 subtype of nicotinic receptor is highly expressed in the hippocampus where it is purported to modulate release of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). The alpha7 receptor-mediated release of GABA is thought to contribute to hippocampal inhibition (gating) of response to repetitive auditory stimulation. This hypothesis is supported by observations of hippocampal auditory gating deficits in mouse strains with low levels of hippocampal alpha7 receptors compared to strains with high levels of hippocampal alpha7 receptors. The difficulty with comparisons between mouse strains, however, is that different strains have different genetic backgrounds. Thus, the observed interstrain differences in hippocampal auditory gating might result from factors other than interstrain variations in the density of hippocampal alpha7 receptors. To address this issue, hippocampal binding of the alpha7 receptor-selective antagonist alpha-bungarotoxin as well as hippocampal auditory gating characteristics were compared in C3H wild type and C3H alpha7 receptor null mutant heterozygous mice. The C3H alpha7 heterozygous mice exhibited significant reductions in hippocampal alpha7 receptor levels and abnormal hippocampal auditory gating compared to the C3H wild type mice. In addition, a general increase in CA3 pyramidal neuron responsivity was observed in the heterozygous mice compared to the wild type mice. These data suggest that decreasing hippocampal alpha7 receptor density results in a profound alteration in hippocampal circuit function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18199426      PMCID: PMC2350239          DOI: 10.1016/j.brainres.2007.12.007

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  63 in total

1.  alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons.

Authors:  A V Buhler; T V Dunwiddie
Journal:  J Neurophysiol       Date:  2002-01       Impact factor: 2.714

2.  Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus.

Authors:  M Alkondon; E X Albuquerque
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

3.  Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors.

Authors:  A V Buhler; T V Dunwiddie
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons.

Authors:  D Ji; J A Dani
Journal:  J Neurophysiol       Date:  2000-05       Impact factor: 2.714

5.  Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus.

Authors:  L Maggi; E Sher; E Cherubini
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

6.  The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

Authors:  B Olivier; C Leahy; T Mullen; R Paylor; V E Groppi; Z Sarnyai; D Brunner
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

7.  Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice.

Authors:  Rudy Schreiber; Marion Dalmus; Jean De Vry
Journal:  Psychopharmacology (Berl)       Date:  2001-10-19       Impact factor: 4.530

8.  Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.

Authors:  R Fabian-Fine; P Skehel; M L Errington; H A Davies; E Sher; M G Stewart; A Fine
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

9.  Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures.

Authors:  Davide Franceschini; Richard Paylor; Ron Broide; Ramiro Salas; Laura Bassetto; Cecilia Gotti; Mariella De Biasi
Journal:  Brain Res Mol Brain Res       Date:  2002-01-31

10.  Cholinergic gating of response to auditory stimuli in rat hippocampus.

Authors:  V Luntz-Leybman; P C Bickford; R Freedman
Journal:  Brain Res       Date:  1992-07-31       Impact factor: 3.252

View more
  17 in total

1.  Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.

Authors:  C E Adams; J C Yonchek; K M Schulz; S L Graw; J Stitzel; P U Teschke; K E Stevens
Journal:  Neuroscience       Date:  2012-01-25       Impact factor: 3.590

2.  Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; Stewart A Anderson; David R Lynch
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

3.  Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.

Authors:  Karen E Stevens; Brandon Cornejo; Catherine E Adams; Lijun Zheng; Joan Yonchek; Keith L Hoffman; Uwe Christians; William R Kem
Journal:  Brain Res       Date:  2010-07-03       Impact factor: 3.252

4.  Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.

Authors:  Jason Smucny; Karen E Stevens; Jason R Tregellas
Journal:  Pharmacol Biochem Behav       Date:  2014-01-10       Impact factor: 3.533

5.  Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.

Authors:  Ronald K Freund; Sharon Graw; Kevin S Choo; Karen E Stevens; Sherry Leonard; Mark L Dell'Acqua
Journal:  Neurosci Lett       Date:  2016-05-24       Impact factor: 3.046

6.  Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.

Authors:  Karen E Stevens; Lijun Zheng; Kirsten L Floyd; Jerry A Stitzel
Journal:  Brain Res       Date:  2015-03-02       Impact factor: 3.252

Review 7.  Genetic matters: thirty years of progress using mouse models in nicotinic research.

Authors:  Michael J Marks
Journal:  Biochem Pharmacol       Date:  2013-06-06       Impact factor: 5.858

8.  Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use.

Authors:  Sharon K Hunter; Michael A Kisley; Lizbeth McCarthy; Robert Freedman; Randal G Ross
Journal:  Schizophr Bull       Date:  2010-04-19       Impact factor: 9.306

Review 9.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

10.  Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels.

Authors:  Nathanial P Brooks; Sharon Mexal; Jerry A Stitzel
Journal:  Brain Res       Date:  2009-02-07       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.